Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Herbal Remove Herbal filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Recommendation provided by Pharmacovigilance Risk Assessment Committee Remove Recommendation provided by Pharmacovigilance Risk Assessment Committee filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (7) Apply Yes filter

Referral type

Article 20 procedures (18) Apply Article 20 procedures filter Article 31 referrals (10) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC Remove PRAC-CHMP-EC filter PRAC-CMDh (15) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (10) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (18) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (18) Apply Risk minimisation measures filter Suspension (4) Apply Suspension filter Variation (4) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (1) Apply Accelerated assessment filter Additional monitoring (14) Apply Additional monitoring filter Exceptional circumstances (1) Apply Exceptional circumstances filter Generic (2) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

28 results

Remove all filtersRemove all filters

Categories Human Remove Human filter Herbal Remove Herbal filter

Referral status European Commission final decision Remove European Commission final decision filter Recommendation provided by Pharmacovigilance Risk Assessment Committee Remove Recommendation provided by Pharmacovigilance Risk Assessment Committee filter

Referral decision making model PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Medicine Referrals Remove Referrals filter

Sort by

List item

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

Cervarix : Bivalent HPV vaccine (types 16, 18) -Gardasil : quadrivalent HPV vaccine (types 6, 11, 16, 18)Gardasil 9 : 9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)Silgard : quadrivalent HPV vaccine (types 6, 11, 16, 18), associated names: Cervarix, Gardasil, Gardasil 9, Silgard, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/11/2015, EC decision date: 12/01/2016, Last updated: 20/01/2016
List item

Referral: Retinoid-containing medicinal products

acitretin, adapalene, alitretinoin, bexarotene, isotretinoin, tretinoin, tazarotene, associated names: Targretin, Panretin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/03/2018, EC decision date: 21/06/2018, Last updated: 02/07/2018
List item

Referral: Ulipristal acetate 5mg medicinal products (updated)

Ulipristal acetate, associated names: Esmya, Ulipristal Acetate Gedeon Richter, Article 31 referrals
Status: European Commission final decision, opinion/position date: 12/11/2020, EC decision date: 11/01/2021, Last updated: 14/01/2021

28 results

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

Referral: Retinoid-containing medicinal products

Referral: Ulipristal acetate 5mg medicinal products (updated)